Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Global Blood Therapeutics, Inc. | Chief Legal Officer | Common Stock | 0 | $46.99 | Oct 5, 2022 | Direct | |
Global Blood Therapeutics, Inc. | Chief Legal Officer | Restricted Stock Units | 0 | Oct 5, 2022 | Direct | ||
Global Blood Therapeutics, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 0 | Oct 5, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GBT | Global Blood Therapeutics, Inc. | Oct 5, 2022 | 13 | $0 | 4 | Oct 6, 2022 | Chief Legal Officer |
GBT | Global Blood Therapeutics, Inc. | Sep 1, 2022 | 6 | -$118K | 4 | Sep 6, 2022 | Chief Legal Officer |
GBT | Global Blood Therapeutics, Inc. | Aug 1, 2022 | 4 | -$68.9K | 4 | Aug 3, 2022 | Chief Legal Officer |
GBT | Global Blood Therapeutics, Inc. | Mar 1, 2022 | 7 | -$17.1K | 4 | Mar 3, 2022 | Chief Legal Officer |
GBT | Global Blood Therapeutics, Inc. | Feb 1, 2022 | 5 | -$102K | 4 | Feb 3, 2022 | Chief Legal Officer |
GBT | Global Blood Therapeutics, Inc. | Sep 1, 2021 | 4 | -$30.2K | 4 | Sep 3, 2021 | Chief Legal Officer |
GBT | Global Blood Therapeutics, Inc. | Aug 1, 2021 | 5 | -$88.8K | 4/A | Sep 24, 2021 | Chief Legal Officer |